K Number
K982860
Device Name
UM-L20/ UM-L30
Date Cleared
1999-08-13

(365 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The UM-L20/UML30 CO2 Laser Units are used in the following applications in order to treat the below mentioned conditions: ENT, Plastic & Reconstruction, Dermatology, Podiatry, Dentalogy, General Practice, Gynecology, Proctology. Specific conditions are listed in tables.
Device Description
Not Found
More Information

Not Found

Not Found

No
The summary describes a CO2 laser unit for various surgical applications and does not mention any AI or ML components or functionalities.

Yes
The "Intended Use / Indications for Use" section states that the device is "used in the following applications in order to treat the below mentioned conditions," which indicates a therapeutic purpose.

No
The "Intended Use / Indications for Use" section states that the device is used for treating conditions in various medical fields, indicating a therapeutic rather than diagnostic purpose.

No

The device is described as a "CO2 Laser Unit," which is a hardware device used for surgical procedures. The summary focuses on the intended use and anatomical sites for this hardware device, not on a software component.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use describes the device as a CO2 laser unit used for treating various medical conditions across different specialties (ENT, Plastic & Reconstruction, Dermatology, etc.). This involves direct interaction with the patient's body for therapeutic purposes.
  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body (like blood, urine, tissue) to detect diseases, conditions, or infections. They are used outside of the body.
  • Lack of IVD Characteristics: The description does not mention any analysis of biological samples, diagnostic testing, or any of the typical components or processes associated with IVDs.

Therefore, the UM-L20/UML30 CO2 Laser Units are therapeutic medical devices, not in vitro diagnostic devices.

N/A

Intended Use / Indications for Use

The UM-L20/UML30 CO2 Laser Units are used in the following applications in order to treat the below mentioned conditions:
ENT: Adenoidectomy, Oral Tumors, Rhinophyma, Tumors, Nasal Polyps, Hemostasis, Rhinitis, Keratosis, Tonsillectomy, Verruce Nevi, Skin Tags
Plastic & Reconstruction: Xanthoma, Nasal Polyps, Condyloma, Rhinitis, Tumors, Telangiectasia, Hemostasis, Rhinophyma, Keloids, Keratosis, Skin Tags, Skin Incisions, Verruce, Nevi
Dermatology: Xanthoma, Telangiectasia, Rhinophyma, Condyloma, Tumors, Hemostasis, Keloids, Verruce, Skin Tags, Nevi, Dark Spots, Corn, Syringoma
Podiatry: Tumors, Hemostasis, Keloids, Verruce, Skin Tags, Nevi, Skin Incision
Dentalogy: Gingival Incision & Excision, Tissue Retraction for Impression, Frenectomy & Frenotomy, Aphthous Ukers, Excisional & Incisional Biopsies, Draining of Abscesses, Hemostatic Assistance, Implant Exposure, Soft Tissue Crown Lengthning, Operculectomy
General Practice: Rhinitis, Tumors, Keloids, Keratosis, Verrucae, Skin Tags, Nevi, Xanthoma, Condyloma
Gynecology: Condyloma, Conization, Tumors, Hemostasis, Keloids, Keratosis, Verrucae, Skin Tags, Nevi
Proctology: Tumors, Hemostasis, Hemorrhoids, Keloids, Keratosis, Verrucae, Skin Tags, Nevi, Skin Incisions

Product codes

GEX

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

ENT, Oral, Nasal, Skin, Gingival, Soft Tissue, Genital, Anal

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Qualified physician only.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

Image /page/0/Picture/1 description: The image is a black and white circular logo for the U.S. Department of Health & Human Services. The logo features the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged in a circle around a central symbol. The symbol consists of three stylized human profiles facing to the right, with flowing lines above them that resemble a bird in flight or a stylized representation of movement or progress.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 13 1999

Union Medical Engineering Co., Ltd. c/o Ms. Annie Velez Director She Medical Systems 1200 N.W. 78th Avenue Suite 110 Miami, Florida 33126

Re: K982860

Trade Name: UM-L20; UM-L30 Carbon Dioxide Laser and Accessories

Regulatory Class: II Product Code: GEX Dated: May 3, 1999 Received: June 21, 1999

Dear Ms. Velez:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

1

Page 2 - Ms. Annie Velez

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

INDICATION FOR USE STATEMENT

510(k) Number: K982860

CO2 Lasers Device Name:

UM-L20/UM-L30 Device Model:

Indications for Use:

The UM-L20/UML30 CO2 Laser Units are used in the following applications in order to treat the below mentioned conditions:

: :

ENTPlastic & ReconstructionDermatologyPodiatry
AdenoidectomyXanthomaXanthomaTumors
Oral TumorsNasal PolypsTelangiectasiaHemostasis
RhinophymaCondylomaRhinophymaKeloids
TumorsRhinitisCondylomaVerruce
Nasal PolypsTumorsTumorsSkin Tags
HemostasisTelangiectasiaHemostasisNevi
RhinitisHemostasisKeloidsSkin Incision
KeratosisRhinophymaVerruce
TonsillectomyKeloidsSkin Tags
Verruce NeviKeratosisNevi
Skin TagsSkin TagsDark Spots
Skin IncisionsCorn
VerruceSyringoma
Nevi

Acote

(Division Sign-Off)
Division of General Restorative Devices K982860
510(k) Number

Prescription Use (Per 21 CFR 801.109)

3

Indication for Use, Page 2 K982860, UM-L20 & UM-L30 CO2 Lasers

Gingival Incision & Excision Tissue Retraction for Impression Frenectomy & Frenotomy Aphthous Ukers Excisional & Incisional Biopsies Draining of Abscesses Hemostatic Assistance Implant Exposure Soft Tissue Crown Lengthning Operculectomy

Dentalogy

General Practice

Rhinitis

Tumors

Keloids

Keratosis

Verrucae

Skin Tags

Nevi

Xanthoma

Condyloma

Gynecology

Proctology

  • Condyloma Conization Tumors Hemostasis Keloids Keratosis Verrucae Skin Tags Nevi
    Tumors Hemostasis Hemorrhoids Keloids Keratosis Verrucae Skin Tags Nevi Skin Incisions

Federal Law restricts the use of this device by or on the order of a qualified physician only.

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use K

OR Over the Counter Use

(Per 21 CFR 801.109)

padilla

Division Sign-Off) Division of General Restorative Devices/ 9822860 510(k) Number